Skip to ContentSkip to Navigation
OnderwijsOpleidingenMaster en PhD opleidingenInnovative Medicine
Header image Innovative Medicine

Innovative Medicine

The Erasmus+ International Master in Innovative Medicine (IMIM) is a two-year master of excellence, focusing on the education of tomorrow's leading translational biomedical researchers.

Do you have the ambition to become a leading translational biomedical researcher? Do you want to receive a degree from the Top-100 Universities of Groningen, Heidelberg and Uppsala? Do you belong to the top of your class? If your answer to these questions is Yes, then the Erasmus+ International Master in Innovative Medicine (IMIM) might be for you!

The Erasmus+ International Master in Innovative Medicine (IMIM) is a European-funded 2-year programme. IMIM was awarded the Erasmus Mundus Joint Master Degree (EMJMD) excellence label in 2015. As an IMIM student, you follow a tailor-made training programme at two or three EU partner universities. Additionally, you have the opportunity to do a research internship at one of IMIM's industry partners or at one of the programme's leading Latin American partner institutions.

The common thread throughout IMIM is the 'From Bench to Bedside and Back' (BBB) Learning Line. BBB helps you get a full perspective on medical sciences, ranging from the underlying basic mechanisms of disease to drug design and the clinical applications of research. The strong IMIM connection with private-sector partners further ensures that you will gain important insights into non-academic perspectives on research. On top of this, you will take part in the IMIM Spring and Summer Schools, designed to foster personal development skills and business savvy.

The Erasmus+ International Master in Innovative Medicine (IMIM) is a two-year master of excellence, focusing on the education of tomorrow's leading translational biomedical researchers.

Do you have the ambition to become a leading translational biomedical researcher? Do you want to receive a degree from the Top-100 Universities of Groningen, Heidelberg and Uppsala? Do you belong to the top of your class? If your answer to these questions is Yes, then the Erasmus+ International Master in Innovative Medicine (IMIM) might be for you!

The Erasmus+ International Master in Innovative Medicine (IMIM) is a European-funded 2-year programme. IMIM was awarded the Erasmus Mundus Joint Master Degree (EMJMD) excellence label in 2015. As an IMIM student, you follow a tailor-made training programme at two or three EU partner universities. Additionally, you have the opportunity to do a research internship at one of IMIM's industry partners or at one of the programme's leading Latin American partner institutions.

The common thread throughout IMIM is the 'From Bench to Bedside and Back' (BBB) Learning Line. BBB helps you get a full perspective on medical sciences, ranging from the underlying basic mechanisms of disease to drug design and the clinical applications of research. The strong IMIM connection with private-sector partners further ensures that you will gain important insights into non-academic perspectives on research. On top of this, you will take part in the IMIM Spring and Summer Schools, designed to foster personal development skills and business savvy.


  • Testimonial van Anna Vidina, student

    'I always seek to apply the science'

    She has two more interviews with Principal Investigators of the University Medical Center Groningen as part of her study programme International Master in Innovative Medicine, or IMIM. Then Anna Vidina (22) will have to decide on a lab where to carry out her internship. ‘There are so many great researchers, that it’s hard to choose.’

    The main topic of this two-year international master of excellence is the translational science. Students gain a full perspective on the medical sciences and their clinical applications. ‘From Bench to Bedside and Back, as it’s called,’ Anna explains. ‘It is quite application-oriented, which I love because it will enable me to apply fundamental knowledge directly in the clinic or industry.’

    Groningen - Uppsala
    Graduates of IMIM receive their degree from the Top-100 EU universities of Groningen, Heidelberg and Uppsala. ‘The international aspect was important to me,’ the Latvian student says. ‘It gives me the opportunity to attend the programmes at at least two of these universities. After Groningen I will finish the master’s track in Uppsala University.’

    Computed tests versus cell experiments
    This first semester was all about coursework and research methods. Next up: the internship. Will it be at a so called wet-lab or rather at a computational biology lab? ‘To find out, I arranged interviews with professors performing research in gene engineering and computational genetics fields. Why bioinformatics and statistics? Data analysis is certainly intriguing. By knowing the molecular interactions and kinetics within a cell, you can set up a computed test. And that means faster results compared to working in the wet-lab, an immense decrease in workload for future researchers and hopefully new breakthroughs on medicine and health practices.’

    Spring and summer
    ‘As a student of IMIM, you have to be pro-active. You have all the possible resources, but it has to come from you to make it work,’ according to Anna. So, to become this leading translational biomedical researcher which the programme promises, all IMIM students additionally participate in five-day Spring and Summer Schools at the partner universities. Anna: ‘These training weeks are designed to develop both personal and business skills. I am especially curious about how entrepreneurship and the industrial perspective on medicine and research have been taken in.’

    Anna’s advice for future IMIM-students:
    ‘Don’t let the admission requirements, application procedure and the fact that you will live in a new country scare you off. I talked about this with my fellow IMIM students, they too were somewhat intimidated to apply. But as it turned out, we were all fit for this. And so can you!’

    Sluiten
    – Anna Vidina, student
Feiten & Cijfers
Titel/Graad
MSc in Medical and Pharmaceutical Drug Innovation
Croho code
60617
Type opleiding
Master
Voertaal
Engels (100%)
Duur
24 maanden (120 ECTS)
Start
SeptemberSeptember
Vorm
voltijd
Faculteit
Medische wetenschappen
printView this page in: English